Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
199
NMPA:199
Drug Approvals
Salbutamol Sulfate Injection
- Product Name
- 硫酸沙丁胺醇注射液
- Approval Number
- 国药准字H20254105
- Approval Date
- May 13, 2025
NMPA
Potassium Aspartate Injection
- Product Name
- 门冬氨酸钾注射液
- Approval Number
- 国药准字H20249698
- Approval Date
- Dec 6, 2024
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20249239
- Approval Date
- Oct 29, 2024
NMPA
Bicarbonate Ringer’s Injection
- Product Name
- 碳酸氢钠林格注射液
- Approval Number
- 国药准字H20244059
- Approval Date
- Jun 18, 2024
NMPA
Potassium Chloride Injection
- Product Name
- 氯化钾注射液
- Approval Number
- 国药准字H20247092
- Approval Date
- May 7, 2024
NMPA
Ropivacaine Hydrochloride Injection
- Product Name
- 盐酸罗哌卡因注射液
- Approval Number
- 国药准字H20243444
- Approval Date
- Apr 7, 2024
NMPA
Ropivacaine Hydrochloride Injection
- Product Name
- 盐酸罗哌卡因注射液
- Approval Number
- 国药准字H20243445
- Approval Date
- Apr 7, 2024
NMPA
Compound Dextran 40 Injection
- Product Name
- 复方右旋糖酐40注射液
- Approval Number
- 国药准字H20090336
- Approval Date
- Mar 6, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 20
- Next
Clinical Trials
No trials found
News
No news found